|Articles|April 28, 2023
Supplements and Featured Publications
- Managed Care Considerations in the Management of CKD Associated With T2D
Managed Care Considerations in the Management of CKD Associated With T2D
Advertisement
This publication was paid for by and developed under the direction of Bayer. It was not peer reviewed. Financial support and promotional content direction were provided by members of Bayer Market Access team.
This AJMC® Clinical Brief describes ways in which payers can optimize management of patients with chronic kidney disease associated with type 2 diabetes.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
3
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
4
How Effective and Safe Are GLP-1s for Weight Loss?
5










































